Cohen A - Search Results

1

The efficacy and safety of pharmacological prophylaxis of venous thromboembolism following elective knee or hip replacement: systematic review and network meta-analysis.

Cohen A, Drost P, Marchant N, Mitchell S, Orme M, Rublee D, Simon TA, Sutton A. Cohen A, et al. Clin Appl Thromb Hemost. 2012 Nov;18(6):611-27. doi: 10.1177/1076029612437579. Epub 2012 Mar 2. Clin Appl Thromb Hemost. 2012. PMID: 22387582 Free article. Review.

2

Pharmacological prevention of venous thromboembolism in medical patients at risk.

Wolozinsky M, Yavin YY, Cohen AT. Wolozinsky M, et al. Am J Cardiovasc Drugs. 2005;5(6):409-15. doi: 10.2165/00129784-200505060-00008. Am J Cardiovasc Drugs. 2005. PMID: 16259529 Review.

3

Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients.

Cohen AT, Alikhan R, Arcelus JI, Bergmann JF, Haas S, Merli GJ, Spyropoulos AC, Tapson VF, Turpie AG. Cohen AT, et al. Thromb Haemost. 2005 Oct;94(4):750-9. Thromb Haemost. 2005. PMID: 16270626 Review.

4

Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial.

Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Cohen AT, et al. BMJ. 2006 Feb 11;332(7537):325-9. doi: 10.1136/bmj.38733.466748.7C. Epub 2006 Jan 26. BMJ. 2006. PMID: 16439370 Free PMC article. Clinical Trial.

5

Postoperative Melagatran/Ximelagatran for the Prevention of Venous Thromboembolism following Major Elective Orthopaedic Surgery : Effects of Timing of First Dose and Risk Factors for Thromboembolism and Bleeding Complications on Efficacy and Safety.

Dahl OE, Eriksson BI, Agnelli G, Cohen AT, Mouret P, Rosencher N, Panfilov S, Bylock A, Andersson M. Dahl OE, et al. Among authors: cohen at. Clin Drug Investig. 2005;25(1):65-77. doi: 10.2165/00044011-200525010-00006. Clin Drug Investig. 2005. PMID: 17523747

6

Venous thromboembolism prophylaxis for the medical patient: where do we stand?

Yavin Y, Cohen AT. Yavin Y, et al. Semin Respir Crit Care Med. 2008 Feb;29(1):75-82. doi: 10.1055/s-2008-1047565. Semin Respir Crit Care Med. 2008. PMID: 18302089 Review.

7

Venous thromboembolism risk and prophylaxis in the acute care hospital setting (ENDORSE survey): findings in surgical patients.

Kakkar AK, Cohen AT, Tapson VF, Bergmann JF, Goldhaber SZ, Deslandes B, Huang W, Anderson FA Jr; ENDORSE Investigators. Kakkar AK, et al. Among authors: cohen at. Ann Surg. 2010 Feb;251(2):330-8. doi: 10.1097/SLA.0b013e3181c0e58f. Ann Surg. 2010. PMID: 20054273

8

VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.

Cohen AT, Nandini B, Wills JO, Ota S. Cohen AT, et al. Thromb Res. 2010 Apr;125 Suppl 2:S21-9. doi: 10.1016/S0049-3848(10)70008-6. Thromb Res. 2010. PMID: 20434000 Review.

9

Idraparinux versus standard therapy in the treatment of deep venous thrombosis in cancer patients: a subgroup analysis of the Van Gogh DVT trial.

van Doormaal FF, Cohen AT, Davidson BL, Decousus H, Gallus AS, Gent M, Piovella F, Prins MH, Raskob GE, Büller HR. van Doormaal FF, et al. Thromb Haemost. 2010 Jul;104(1):86-91. doi: 10.1160/TH09-12-0870. Epub 2010 May 27. Thromb Haemost. 2010. PMID: 20508907 Clinical Trial.

10

Prevention of VTE in women with cancer.

Cohen AT, Wills JO, Bharathi N, Solis JV. Cohen AT, et al. Thromb Res. 2011 Feb;127 Suppl 3:S5-8. doi: 10.1016/S0049-3848(11)70003-2. Thromb Res. 2011. PMID: 21262440

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,873 results

Search Page

Filters